| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/31/2002 | EP1227097A1 Ucs1025 derivatives |
| 07/31/2002 | EP1226153A2 Fluorescent cobalamins and uses thereof |
| 07/31/2002 | EP1226144A1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 07/31/2002 | EP1226138A1 Fab i inhibitors |
| 07/31/2002 | EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 07/31/2002 | CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them |
| 07/31/2002 | CN1361779A New compounds |
| 07/30/2002 | US6426059 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 07/30/2002 | CA2103554C Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents |
| 07/25/2002 | WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage |
| 07/25/2002 | WO2002057425A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057287A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057269A1 Synthesis of temozolomide and analogs |
| 07/25/2002 | WO2002057268A1 Synthesis of temozolomide and analogs |
| 07/25/2002 | WO2002057267A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 07/25/2002 | WO2002057266A1 Improved process for carbapenem synthesis |
| 07/25/2002 | WO2002057265A1 Compounds substituted with bicyclic amino groups |
| 07/25/2002 | WO2002057264A1 Pyrrole derivates for treating cytokine mediated diseases |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | WO2002056964A1 Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 07/25/2002 | WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/25/2002 | WO2002032901A3 Bridged piperazine derivatives |
| 07/25/2002 | WO2002002519A3 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/25/2002 | WO2002000653A3 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 07/25/2002 | WO2001068096A3 Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
| 07/25/2002 | US20020099217 Process for preparing azacycloalkanoylaminothiazoles |
| 07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
| 07/25/2002 | US20020099204 For use in optical recording of information for writable recording media |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099068 I kappa B kinase inhibitors for treating various disorders including arthritis |
| 07/25/2002 | US20020099061 5-amino-pyrazolo-(4, 3-e)-1,2,4-triazolo(1,5-c)pyrimidine adenosine A2a receptor antagonists; use in the treatment of central nervous system diseases, in particular Parkinson's disease |
| 07/25/2002 | US20020099055 Novel compounds |
| 07/25/2002 | CA2435692A1 Pyrrole derivates for treating cytokine mediated diseases |
| 07/25/2002 | CA2434300A1 Synthesis of temozolomide and analogs |
| 07/25/2002 | CA2430577A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP0970085B1 Photoactivatable nitrogen-containing bases based on alpha-amino alkenes |
| 07/24/2002 | EP0934527B1 Non radioactive receptor assay suitable for quantitative and qualitative analysis of trace amounts of receptor binding analyte |
| 07/24/2002 | EP0836485B1 Cascade polymer complexes |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | CN1360588A Hemisynthetic method and intermediate thereof |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1360580A Substd. benzoyl ketones, methods for producing them and their use as herbicides |
| 07/24/2002 | CN1088063C Sulfmidyl (thio) carbonyl-1,2,4-triazolineone deriv. and preparation method and application as weed killer |
| 07/24/2002 | CN1088062C Certain 4-aminomethy-2-substd. imidazole derivs. and 2-aminomethyl-4-substd. imidazole derivs. new classes of dopamine receptor subtype specific ligands |
| 07/23/2002 | US6423844 Reacting 2,4-diamino-6-hydrazino-s-triazine with a nitrile compound |
| 07/23/2002 | US6423842 Act preferentially on m4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; alzheimer's disease; cognition activators. |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423716 Nitrogenous heterocyclic compounds |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | CA2067069C Novel diketopyrrolopyrroles |
| 07/18/2002 | WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055084A1 PYRROLO[2,3-d]PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055083A1 TRIAZOLO[4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055082A1 Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 07/18/2002 | WO2002036595A3 N-(5,7-DIMETHOXY[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YL) ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES |
| 07/18/2002 | WO2002006287A9 Macrocyclic mri contrast agents |
| 07/18/2002 | WO2001082920A3 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 07/18/2002 | US20020095054 Process to produce oxazolidinones |
| 07/18/2002 | US20020095036 Synthesis of temozolomide and analogs |
| 07/18/2002 | US20020095034 Imipenem production process |
| 07/18/2002 | US20020094999 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias |
| 07/18/2002 | US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 07/18/2002 | US20020094974 N-6 Substituted 7-deazapurines selectively binding to the adenosine 3 receptor; bronchitis, gastrointestinal disorders, asthma, allergic rhinitis, chronic obstructive pulmonary disease, vision defects, arthritis, autoimmune disease |
| 07/18/2002 | US20020094936 Fungicidal activity |
| 07/18/2002 | US20020094935 N-([1,2,4] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides |
| 07/18/2002 | CA2434006A1 Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists |
| 07/18/2002 | CA2433997A1 Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 07/18/2002 | CA2433084A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | CA2432114A1 4-(hetero)aryl substituted indolinones |
| 07/17/2002 | EP1223176A2 Peptide mutant of human ERAB/HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 07/17/2002 | EP1223172A2 Process for the production of pure triethylene diamine (TEDA) |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222190A1 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors |
| 07/17/2002 | EP1222189A2 PROCESS FOR THE PREPARATION OF PYRIMIDO 5,4-g]PTERIDINE DERIVATIVES |
| 07/17/2002 | EP1066293B1 New porphyrins and their use |
| 07/17/2002 | EP0946563B1 Method of obtaining haemin from slaughter blood |
| 07/17/2002 | EP0801568B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/17/2002 | EP0686156B1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 07/17/2002 | CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 07/17/2002 | CN1358723A Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/17/2002 | CN1358722A Process for preparing citrat |
| 07/17/2002 | CN1087744C Ruthenium (II) polypyridine match and its preparing process |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087725C Enhancement of the effect of drugs by deuteration |
| 07/16/2002 | US6420648 Light harvesting arrays |
| 07/16/2002 | US6420557 For therapy of male erectile dysfunction |
| 07/16/2002 | US6420553 Metallization a porphyrin to form metalloporprin |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420384 Proton pump inhibitors |
| 07/16/2002 | US6420370 Pyrimidine derivatives and method of making and using derivatives |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420363 Mono- or polyenic carboxylic acid derivatives |